GGHCX vs. FBIOX
Compare and contrast key facts about Invesco Health Care Fund (GGHCX) and Fidelity Select Biotechnology Portfolio (FBIOX).
GGHCX is managed by Invesco. It was launched on Aug 6, 1989. FBIOX is managed by Fidelity. It was launched on Dec 16, 1985.
Performance
GGHCX vs. FBIOX - Performance Comparison
Loading graphics...
GGHCX vs. FBIOX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GGHCX Invesco Health Care Fund | -8.65% | 15.48% | 3.96% | 3.05% | -13.53% | 12.05% | 14.52% | 32.01% | 0.27% | 15.51% |
FBIOX Fidelity Select Biotechnology Portfolio | -3.22% | 36.38% | 7.26% | 10.09% | -15.87% | -12.26% | 38.62% | 36.12% | -10.92% | 27.87% |
Returns By Period
In the year-to-date period, GGHCX achieves a -8.65% return, which is significantly lower than FBIOX's -3.22% return. Over the past 10 years, GGHCX has underperformed FBIOX with an annualized return of 6.75%, while FBIOX has yielded a comparatively higher 9.85% annualized return.
GGHCX
- 1D
- 0.65%
- 1M
- -8.58%
- YTD
- -8.65%
- 6M
- -1.69%
- 1Y
- 1.85%
- 3Y*
- 5.07%
- 5Y*
- 2.41%
- 10Y*
- 6.75%
FBIOX
- 1D
- 0.08%
- 1M
- -6.89%
- YTD
- -3.22%
- 6M
- 11.54%
- 1Y
- 33.83%
- 3Y*
- 17.53%
- 5Y*
- 3.77%
- 10Y*
- 9.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GGHCX vs. FBIOX - Expense Ratio Comparison
GGHCX has a 1.04% expense ratio, which is higher than FBIOX's 0.69% expense ratio.
Return for Risk
GGHCX vs. FBIOX — Risk / Return Rank
GGHCX
FBIOX
GGHCX vs. FBIOX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care Fund (GGHCX) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GGHCX | FBIOX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.12 | 1.35 | -1.22 |
Sortino ratioReturn per unit of downside risk | 0.28 | 1.84 | -1.56 |
Omega ratioGain probability vs. loss probability | 1.04 | 1.24 | -0.20 |
Calmar ratioReturn relative to maximum drawdown | 0.10 | 2.10 | -1.99 |
Martin ratioReturn relative to average drawdown | 0.32 | 7.73 | -7.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GGHCX | FBIOX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.12 | 1.35 | -1.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.16 | 0.15 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | 0.37 | +0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.47 | +0.09 |
Correlation
The correlation between GGHCX and FBIOX is 0.77, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
GGHCX vs. FBIOX - Dividend Comparison
GGHCX's dividend yield for the trailing twelve months is around 6.22%, more than FBIOX's 2.55% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GGHCX Invesco Health Care Fund | 6.22% | 5.69% | 5.17% | 0.00% | 0.00% | 24.69% | 6.44% | 3.51% | 8.81% | 6.88% | 2.24% | 15.07% |
FBIOX Fidelity Select Biotechnology Portfolio | 2.55% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
Drawdowns
GGHCX vs. FBIOX - Drawdown Comparison
The maximum GGHCX drawdown since its inception was -40.23%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for GGHCX and FBIOX.
Loading graphics...
Drawdown Indicators
| GGHCX | FBIOX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.23% | -71.98% | +31.75% |
Max Drawdown (1Y)Largest decline over 1 year | -13.53% | -12.27% | -1.26% |
Max Drawdown (5Y)Largest decline over 5 years | -25.37% | -44.87% | +19.50% |
Max Drawdown (10Y)Largest decline over 10 years | -29.34% | -48.66% | +19.32% |
Current DrawdownCurrent decline from peak | -12.96% | -7.32% | -5.64% |
Average DrawdownAverage peak-to-trough decline | -8.82% | -23.72% | +14.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 4.05% | +0.36% |
Volatility
GGHCX vs. FBIOX - Volatility Comparison
The current volatility for Invesco Health Care Fund (GGHCX) is 4.60%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 7.30%. This indicates that GGHCX experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GGHCX | FBIOX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.60% | 7.30% | -2.70% |
Volatility (6M)Calculated over the trailing 6-month period | 9.05% | 14.68% | -5.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.67% | 23.91% | -8.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.50% | 24.85% | -9.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.49% | 26.38% | -8.89% |